3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
92
Myelodysplastic Syndromes
59
Leukemia
30
Leukemia, Myelomonocytic, Chronic
27
Neoplasms
10
Carcinoma, Non-Small-Cell Lung
9
Multiple Myeloma
8
Recurrence
7
Lymphoma
7
Primary Myelofibrosis
6
Myeloproliferative Disorders
5
Hematologic Neoplasms
5
Prostatic Neoplasms
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Neoplasm Metastasis
4
Lymphoma, Non-Hodgkin
4
Lymphoma, Large B-Cell, Diffuse
4
Leukemia, Myelomonocytic, Acute
4
Leukemia, Erythroblastic, Acute
4
Congenital Abnormalities
4
Breast Neoplasms
4
Anemia, Refractory, with Excess of Blasts
4
Pancreatic Neoplasms
3
Leukemia, Monocytic, Acute
3
Leukemia, Megakaryoblastic, Acute
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Leukemia, Biphenotypic, Acute
3
Head and Neck Neoplasms
3
Colorectal Neoplasms
3
Renal Insufficiency
2
Interventions
pembrolizumab
3
Nivolumab
2
vicriviroc
1
spartalizumab
1
relatlimab
1
copanlisib
1
binimetinib
1
Oxaliplatin
1
Leucovorin
1
Irinotecan
1
Fluorouracil
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Spinocerebellar Degenerations
×
Azacitidine
×
Clear all
No trials found.